Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
Bladder cancer is the second most common urological malignancy in the world. In 70% of cases it is initially diagnosed as non-muscle-invasive bladder cancer (NMIBC) and it is amenable to local treatments, with intravesical (IVES) Bacillus-Calmette-Guerin (BCG) immunotherapy being routinely used afte...
Main Authors: | Rim Hojeij, Sonia Domingos-Pereira, Marianne Nkosi, Dalila Gharbi, Laurent Derré, John T. Schiller, Patrice Jichlinski, Denise Nardelli-Haefliger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/7/1125 |
Similar Items
-
Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
by: Paulina N. Naupu, et al.
Published: (2020-12-01) -
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells
by: H Barzegar, et al.
Published: (2017-11-01) -
Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
by: Sven-Eric Olsson, et al.
Published: (2020-12-01) -
Bacterial Immunogenicity Prediction by Machine Learning Methods
by: Ivan Dimitrov, et al.
Published: (2020-11-01) -
Rodent Papillomaviruses
by: Aayushi Uberoi, et al.
Published: (2017-11-01)